Cite

HARVARD Citation

    Qualls, D. et al. (2023). Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era. British journal of haematology. pp. 524-527. [Online]. 
  
Back to record